Mesothelioma Trials: Efficacy Study of Milataxel (TL139)

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

The Fairfield, New Jersey-based drug research & development company Taxolog Inc. is currently conducting a clinical trial study of the effects of Milataxel in the treatment of malignant mesothelioma. In this Phase II study, patients will be given doses of the experimental drug in order to determine the drug’s response rate.

The study is being conducted at the University of Chicago and Rush University Medical Center, both located in Chicago, Illinois, as well as at the New York University Cancer Center. Further information about this study may be obtained from Harvey Pass, M.D. at New York University.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease. If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.